pancreatitis

Pharma

FDA approves transformational expansion of Ionis’ Tryngolza

Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.

Kevin Dunleavy Jun 25, 2026 8:13am

Novo weight-loss drugs pose risk of stomach problems: study

Oct 6, 2023 12:55pm

Eddie the Enzyme Allergan Zenpep spokescharacter

New Allergan character bows for Zenpep

Apr 2, 2018 9:48am

FDA warns of pancreatitis deaths from Allergan's Viberzi

Mar 16, 2017 10:52am